Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

The unlikely way Trump is helping
Economy Opinion

Pattrick Smellie: The unlikely way Trump is helping

The Trump tariff blitz is creating political opportunity in unlikely places.

NZ at the forefront of fusion energy innovation
Opinion

Tina Schirr: NZ at the forefront of fusion energy innovation

NZ has the potential to play a significant role in fusion energy.

Markets: it’s always the right time
Opinion

Simon Robertson: Markets: it’s always the right time

Following the tariff crash, Q1 newsletters will make for some great reading. 

Simon Robertson 12 Apr 2025
NZDF tech upgrades a case of playing catch-up
Opinion

Peter Griffin: NZDF tech upgrades a case of playing catch-up

If executed well, the defence spending increase will give us entry-level status.

Peter Griffin 09 Apr 2025